Related Experiment Video
Updated: Dec 21, 2025

09:23
Isolation of Microvascular Endothelial Tubes from Mouse Resistance Arteries
Published on: November 25, 2013
16.0K
Endothelial TRPV4 channels and vasodilator reactivity
Yen-Lin Chen1, Swapnil K Sonkusare2
1Robert M. Berne Cardiovascular Research Center, University of Virginia-School of Medicine, Charlottesville, VA, United States.
Current Topics in Membranes
|May 14, 2020
Summary
Transient receptor potential vanilloid 4 (TRPV4) channels in endothelial cells are key for vasodilation. Understanding TRPV4
Area of Science:
- Cardiovascular Physiology
- Ion Channel Biology
- Endothelial Cell Function
Background:
- Endothelial Transient Receptor Potential Vanilloid 4 (TRPV4) ion channels facilitate calcium influx, promoting endothelium-dependent vasodilation.
- Downstream targets of endothelial TRPV4 channels exhibit heterogeneity across vascular beds, indicating endothelial cell diversity.
- The physiological role of endothelial TRPV4 channels remains elusive due to the absence of specific knockout models.
Purpose of the Study:
- To elucidate the signaling mechanisms and physiological relevance of endothelial TRPV4 channels.
- To explore the heterogeneity of TRPV4 activators and targets in different vascular beds.
- To investigate the role of endothelial TRPV4 channels in cardiovascular disease pathogenesis.
Main Methods:
- Review of existing pharmacological studies on endothelial TRPV4 channels.
- Discussion of potential endothelium-specific knockout models.
- Analysis of signaling pathways and disease associations.
Main Results:
- Endothelial TRPV4 channel activity is impaired in cardiovascular diseases, contributing to vascular dysfunction.
- Loss of endothelium-dependent vasodilation is a hallmark of cardiovascular pathology.
- Targeting mechanisms that modulate endothelial TRPV4 activity may offer therapeutic benefits.
Conclusions:
- Endothelial TRPV4 channels are critical for vascular health and function.
- Dysfunctional TRPV4 channels are implicated in cardiovascular disease.
- Future research on TRPV4 signaling may yield novel therapeutic strategies for vascular disorders.
Related Concept Videos
Antihypertensive Drugs: Vasodilators
1.9K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
1.9K
Vascular Resistance
9.5K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
9.5K
Autoregulation of Blood Flow
7.3K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
7.3K
Adrenergic Receptors: β Subtype
3.3K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.3K
Vascular Spasm
3.0K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
3.0K
Nitric Oxide Signaling Pathway
6.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.0K

